Company intelligence / Profile preview
Riboxx Pharmaceuticals
Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
Riboxx Pharmaceuticals develops immunotherapy drugs that activate the innate immune system through toll-like receptor agonists. The company has successfully achieved industrial GMP manufacturing of RIBOXXIM and offers four proprietary drug families for both cancer immunotherapy and viral disease vaccination.[1][2][7]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- RNA therapyVaccine
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Riboxx Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Riboxx Pharmaceuticals.